PRRT2 and Alzheimer disease: The loss of synaptogenic action of PKCɛ, its protective effects against neurogenic factors, lower levels of PKCɛ in the hippocampal area of AD brain are significant markers to distinguish AD from other disorders (Hongpaisan, Sun, & Alkon, 2011; Nelson, Sun, Hongpaisan, & Alkon, 2008).